Redeye has a positive take on the news that Egetis has been granted a rolling NDA review based on cu...
Redeye’s outlook on Dynavox remains stable after another strong report.
* NOI -1% and rec PTP +2% vs ABGSCe * EC IFPM -3.4% q-o-q, partly due to cash position, ready for M&...
* Rec. PTP -4% vs ABGSCe * Occupancy flat q-o-q, as are values * Share to underperform the sector to...
* Q3 EBITDA NOK 14m vs ABGSCe NOK 9m * Awaiting stabilised markets * Only minor adjustments to estim...
Vaisala’s Q3’25 results were clearly better than estimated in terms of both revenue and profitabilit...
Redeye provides its initial commentary on Nanologica following the Q3 2025 report.
* A new divestment by Qben Infra... * ...selling Kvalitetsbygg R AB.
Fiskars Q3 adjusted EBIT of EUR 13.9m came 24% (EUR 4.
* Sales -1% vs. ABGSCe (-7% y-o-y), adj. EBIT -8% vs.
* Adj. EBITA 6% vs ABGSC, 1% vs consensus * Norway drove beat; cash flow solid and gearing down to 2...
Redeye notes that Enea’s Q3 2025 report was lacklustre, with reported sales 9% below Redeye’s foreca...
Redeye gives its initial take on BONESUPPORT’s Q3 report.
Redeye comments on SHH’s Q3 2025 report. SSH reported a 6% year-over-year (Y/Y) growth, slightly low...
Sales -7% vs. ABGSCe at SEK 63m * International expansion weighs on earnings * Likely negative conse...
Redeye provides its initial comments on Stille following the Q3 2025 report, which came in below our...
Redeye comments on Litium’s Q3 report, which included a solid organic ARR growth of 11%.
Redeye comments on Fractal Gaming Group’s Q3 2025 report, which came in soft on the headline figures...
Redeye comments on Teneo AI’s Q3 report showing roughly flat q/q ARR growth while the pipeline conti...
* Q3e sales up 14% y-o-y, 7% organic, supported by order intake * Estimate seasonally strong 9.
